Fenton Mary Kay (CIK 1378589) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-02). Recent activity: Buy CGEM (1,541 shares), Sell CGEM (4,398 shares), Buy CGEM (68,750 shares), Buy CGEM (27 shares), Buy CGEM (60,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-02 | Cullinan Therapeutics, Inc. (CGEM) | Chief Financial Officer | Buy | 1,541 | $13,253 |
| 2026-02-23 | Cullinan Therapeutics, Inc. (CGEM) | Chief Financial Officer | Sell | 4,398 | $59,901 |
| 2026-02-19 | Cullinan Therapeutics, Inc. (CGEM) | Chief Financial Officer | Buy | 68,750 | $0 |
| 2026-01-05 | Cullinan Therapeutics, Inc. (CGEM) | Chief Financial Officer | Buy | 27 | $175 |
| 2025-02-21 | Cullinan Therapeutics, Inc. (CGEM) | Chief Financial Officer | Buy | 60,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-02